Kobe, Japan

Takanori Komaki

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Sysmex Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takanori Komaki. Retrieved from https://idiyas.com/inventor/takanori-komaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takanori Komaki: Innovator in Hemolytic Reagents

Introduction

Takanori Komaki is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of medical reagents, particularly in the classification of white blood cells. His innovative work has led to the development of a unique hemolytic reagent that is essential for various medical applications.

Latest Patents

Takanori Komaki holds 1 patent for his invention titled "Hemolytic reagent, reagent kit, and method for classifying white blood cells." This patent discloses a hemolytic reagent comprising a nonionic surfactant represented by a specific formula. His invention plays a crucial role in enhancing the accuracy and efficiency of blood cell classification.

Career Highlights

Takanori Komaki is associated with Sysmex Corporation, a leading company in the field of medical diagnostics. His work at Sysmex has allowed him to focus on developing innovative solutions that improve healthcare outcomes. His expertise in reagent development has positioned him as a key figure in his field.

Collaborations

Throughout his career, Takanori has collaborated with talented individuals such as Daisuke Yokoyama and Masaki Abe. These collaborations have fostered a creative environment that encourages innovation and the advancement of medical technologies.

Conclusion

Takanori Komaki's contributions to the field of hemolytic reagents exemplify the impact of innovation in medical diagnostics. His work continues to influence the way white blood cells are classified, ultimately benefiting healthcare practices.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…